Fig. 8. General chemoenzymatic strategy for drug conjugation to the conserved glycan of mAbs for the construction of homogenous ADCs. The strategy consists of glycan remodelling that allows the incorporation of non-natural azide-tagged carbohydrate motif (GalNAc94 or Sia93) followed by SPAAC ligation with a suitable payload.
